"Kaplan-Meier Estimate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
Descriptor ID |
D053208
|
MeSH Number(s) |
E05.318.740.998.650 N05.715.360.750.795.650 N06.850.520.830.998.650
|
Concept/Terms |
Kaplan-Meier Estimate- Kaplan-Meier Estimate
- Estimate, Kaplan-Meier
- Kaplan-Meier Test
- Kaplan Meier Test
- Test, Kaplan-Meier
- Product-Limit Method
- Method, Product-Limit
- Methods, Product-Limit
- Product Limit Method
- Product-Limit Methods
- Kaplan-Meier Analysis
- Analysis, Kaplan-Meier
- Kaplan Meier Analysis
Kaplan-Meier Survival Curves- Kaplan-Meier Survival Curves
- Curves, Kaplan-Meier Survival
- Kaplan Meier Survival Curves
- Survival Curves, Kaplan-Meier
|
Below are MeSH descriptors whose meaning is more general than "Kaplan-Meier Estimate".
Below are MeSH descriptors whose meaning is more specific than "Kaplan-Meier Estimate".
This graph shows the total number of publications written about "Kaplan-Meier Estimate" by people in this website by year, and whether "Kaplan-Meier Estimate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 0 | 3 | 3 |
2013 | 0 | 6 | 6 |
2014 | 0 | 4 | 4 |
2015 | 0 | 2 | 2 |
2016 | 0 | 2 | 2 |
2017 | 0 | 4 | 4 |
2018 | 0 | 4 | 4 |
2019 | 0 | 4 | 4 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kaplan-Meier Estimate" by people in Profiles.
-
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis. Sci Rep. 2021 10 05; 11(1):19787.
-
Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID. Nat Commun. 2019 12 05; 10(1):5563.
-
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer. Int J Mol Sci. 2019 Oct 31; 20(21).
-
Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients. Breast Cancer Res Treat. 2020 Jan; 179(2):403-414.
-
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study. BMC Cancer. 2019 Jun 21; 19(1):611.
-
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer. Breast Cancer Res Treat. 2018 Nov; 172(1):93-104.
-
Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09. Leuk Lymphoma. 2019 01; 60(1):60-68.
-
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer. BMC Cancer. 2018 May 08; 18(1):541.
-
Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study. Clin Breast Cancer. 2018 04; 18(2):175-183.
-
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy. Immunity. 2017 10 17; 47(4):789-802.e9.